newsfilter
← Latest News
GlobeNewswire·

Zogenix Receives Orphan Drug Designation for FINTEPLA® (Fenfluramine) in Japan

Zogenix plans to submit a new drug application (J-NDA) for FINTEPLA in Japan for the treatment of seizures associated with Dravet syndrome by year end. Dravet syndrome is a rare, life-long form of epilepsy marked by severe seizures, significant develop